浏览全部资源
扫码关注微信
- Journal Information
- Archive
- Submission
- For Reviewers
- Statement and Policies
Establishment and application of evaluation criteria for clinical rational drug use of atosiban based on AHP-TOPSIS method
- ZHONGGUO YAOFANG Vol. 34, Issue 1, Pages: 86-90(2023)
- 作者机构：
1.广州医科大学附属第三医院药学部，广州 510150
2.广东省产科重大疾病重点实验室，广州 510150
3.广州医科大学附属第三医院产科，广州 510150
- 作者简介：
- 基金信息：
DOI：10.6039/j.issn.1001-0408.2023.01.17
CLC： R984Published：15 January 2023，
Received：23 June 2022，
Revised：08 October 2022，
扫 描 看 全 文
殷锦锦,杜培丽,谭湘萍等.基于AHP-TOPSIS法的阿托西班临床合理用药评价标准的建立与应用 Δ[J].中国药房,2023,34(01):86-90.
YIN Jinjin,DU Peili,TAN Xiangping,et al.Establishment and application of evaluation criteria for clinical rational drug use of atosiban based on AHP-TOPSIS method[J].ZHONGGUO YAOFANG,2023,34(01):86-90.
殷锦锦,杜培丽,谭湘萍等.基于AHP-TOPSIS法的阿托西班临床合理用药评价标准的建立与应用 Δ[J].中国药房,2023,34(01):86-90. DOI： 10.6039/j.issn.1001-0408.2023.01.17.
YIN Jinjin,DU Peili,TAN Xiangping,et al.Establishment and application of evaluation criteria for clinical rational drug use of atosiban based on AHP-TOPSIS method[J].ZHONGGUO YAOFANG,2023,34(01):86-90. DOI： 10.6039/j.issn.1001-0408.2023.01.17.
摘要
目的
2
建立阿托西班的临床合理用药评价标准，为临床合理使用阿托西班提供参考。
方法
2
以醋酸阿托西班注射液说明书、相关指南为依据，由合理用药评价小组制定合理用药评价标准，包括5个一级指标、8个二级指标。采用层次分析（AHP）法计算二级指标的权重系数，利用逼近理想值排序（TOPSIS）法对广州医科大学附属第三医院（以下简称“本院”）190例妊娠期妇女使用醋酸阿托西班注射液的情况进行回顾性评价，根据相对接近度将评价结果分为用药合理、用药基本合理、用药不合理3个层次。
结果
2
190例妊娠期妇女中，49例（25.8%）为阿托西班用药合理，39例（20.5%）为用药基本合理，102例（53.7%）为用药不合理；AHP-TOPSIS法所得评价结果与临床实际情况相符。用药不合理的主要问题为超适应证用药、用法用量不合理、超疗程用药及未进行适宜的经济性考量。
结论
2
通过AHP-TOPSIS法建立了阿托西班临床应用的合理性评价标准，该法所得评价结果可量化、科学可信。该药在本院的不合理使用现象较为普遍，临床应用时应加强管理。
Abstract
OBJECTIVE
2
To establish evaluation criteria for rational drug use of atosiban in clinic， and to provide reference for rational drug use of atosiban in clinic.
METHODS
2
Based on the drug instructions of atosiban acetate injection and related guidelines， the experts of the Evaluation Group of Rational Drug Use formulated the evaluation criteria of rational drug use， including 5 primary indexes and 8 secondary indexes. The weight coefficients of secondary indexes were calculated by analytic hierarchy process （AHP）， and the use of atosiban acetate injection in 190 pregnant women from the Third Affiliated Hospital of Guangzhou Medical University （referred to as “our hospital”） was evaluated retrospectively by technique for order preference by similarity to an ideal solution （TOPSIS）. The evaluation results were divided into three levels including reasonable， basic reasonable and unreasonable application based on the relative approach degree.
RESULTS
2
Among 190 pregnant women， 49 （25.8%） were treated with atosiban reasonably， 39 （20.5%） were treated with atosiban basic reasonably， and 102 （53.7%） were treated with atosiban unreasonably. The evaluation results obtained by AHP-TOPSIS method were consistent with the actual situation in clinic. The main problems of the unreasonably use were super indications， unreasonable usage and dosage， over the course of treatment and the lack of proper economic consideration.
CONCLUSIONS
2
The rationality evaluation criteria of atosiban’s clinical application are established by AHP-TOPSIS method； the evaluation results obtained by this method are quantifiable， scientific and reliable. The unreasonable use of atosiban is common in our hospital， and the management should be strengthened in clinical application.
关键词
阿托西班合理用药评价标准层次分析法逼近理想值排序法
Keywords
rational drug useevaluation criteriaanalytic hierarchy processtechnique for order preference by similarity to an ideal solution
references
WALANI S R. Global burden of preterm birth[J]. Int J Gynaecol Obstet，2020，150（1）：31-33.
Queensland Clinical Guidelines. Preterm labour and birth[EB/OL].（2020-06-24）[2022-06-23] .http：//www.health.qld.gov.au/qcghttp://www.health.qld.gov.au/qcg.
OCHSENBEIN-KÖLBLE N，KRÄHENMANN F，HÜSLER M，et al. Tocolysis for in utero surgery：atosiban performs distinctly better than magnesium sulfate[J]. Fetal Diagn Ther，2018，44（1）：59-64.
VAN VLIET E O G，NIJMAN T A J，SCHUIT E，et al. Nifedipine versus atosiban for threatened preterm birth （APOSTEL Ⅲ）：a multicentre，randomised controlled trial[J]. Lancet，2016，387（10033）：2117-2124.
XU Y J，RAN L M，ZHAI S S，et al. Evaluation of the efficacy of atosiban in pregnant women with threatened preterm labor associated with assisted reproductive techno-logy[J]. Eur Rev Med Pharmacol Sci，2016，20（9）：1881-1887.
HOURBRACQ M，MATTUIZZI A，MADAR H，et al. Non-cardiogenic pulmonary edema in a woman treated with atosiban for preterm labor[J]. Eur J Obstet Gynecol Reprod Biol，2017，219：132-133.
FERNÁNDEZ A，DOMÍNGUEZ D，DELGADO L. Severe non-cardiogenic pulmonary oedema secondary to atosiban and steroids[J]. Int J Obstet Anesth，2011，20（2）：189-190.
DONDERS G G，VAN KEIRSBILCK J，DE ROO T，et al. Non-cardiogenic lung edema in a woman treated with atosiban for preterm labor[J]. J Perinat Med，2008，36（5）：455-457.
SEINEN L H M，SIMONS S O，VAN DER DRIFT M A，et al. Maternal pulmonary oedema due to the use of atosiban in cases of multiple gestation[J]. Ned Tijdschr Geneeskd，2013，157（1）：A5316.
WRIGHT G A，LEVY D M. Atosiban and non-cardiogenic pulmonary oedema[J]. Int J Obstet Anesth，2012，21（1）：98-99.
CHEN R C，JIANG H Q，HUANG C Y，et al. Clinical decision support system for diabetes based on ontology reasoning and TOPSIS analysis[J]. J Healthc Eng，2017，2017：4307508.
KHAN I，PINTELON L，MARTIN H. The application of multicriteria decision analysis methods in health care：a literature review[J]. Med Decis Making，2022，42（2）：262-274.
American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins：Obstetrics. Practice bulletin No. 171：management of preterm labor[J]. Obstet Gynecol，2016，128（4）：e155-e164.
胡娅莉. 早产临床诊断与治疗指南：2014[J]. 中华妇产科杂志，2014，49（7）：481-485.
THOMSON A J，Royal College of Obstetricians and Gynaecologists. Care of women presenting with suspected preterm prelabour rupture of membranes from 24+0 weeks of gestation：green-top guideline [J]. BJOG，2019，126（9）：e152-e166.
SHENNAN A H， STORY L，Royal College of Obstetricians, Gynaecologists. Cervical cerclage： green-top guideline No. 75[J]. BJOG，2022，129（7）：1178-1210.
刘莹昕，刘飒，王威尧. 层次分析法的权重计算及其应用[J]. 沈阳大学学报（自然科学版），2014，26（5）：372-375.
刘一，梁馨玉，宋佳伟，等. AHP-TOPSIS法量化评价我院骨科Ⅰ类切口手术预防性使用抗菌药物的合理性[J]. 中国药房，2021，32（5）：623-629.
李燕，沈爱宗，朱鹏里，等. 分层加权TOPSIS法在某院沙格列汀合理用药评价中的应用[J]. 中国药房，2020，31（5）：627-632.
赵小丽，朱倩倩，赵佩，等. 基于加权TOPSIS法评价重组人血小板生成素的合理使用[J]. 中国医院药学杂志，2022，42（4）：431-434.
刘小艳，王然，冯欣. 153例阿托西班合理用药分析[J]. 中国药业，2019，28（2）：82-84.
GOODWIN T M，VALENZUELA G J，SILVER H，et al．Dose ranging study of the oxytocin antagonist atosiban in the treatment of preperm labor[J]. Obstet Gynecol，1996，88（3）：331-336.
RICHTER O N，DORN C，VAN DE VONDEL P，et al. Tocolysis with atosiban：experience in the management of premature labor before 24 weeks of pregnancy[J]. Arch Gynecol Obstet，2005，272（1）：26-30.
PAPATSONIS D，FLENADY V，LILEY H. Maintenance therapy with oxytocin antagonists for inhibiting preterm birth after threatened preterm labour[J]. Cochrane Database Syst Rev，2009（1）：CD005938.
YONEDA S. Method to evaluate intravenous maintenance tocolysis for preterm labor[J]. J Obstet Gynaecol Res，2020，46（12）：2518-2525.
0
Views
3
下载量
0
CSCD
- L-PDFDownload
- WORDDownload
- Meta-XMLDownload
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Publicity Resources
Related Articles
Related Author
Related Institution
- Address：8/F,129 Daping Main Street,Yuzhong District,Chongqing 400042,P.R.China
- Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号
公网安备50010302001817 - It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
- Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.